China Meheco Co Ltd
China Meheco Group Co., Ltd. engages in the manufacture, marketing, and trade of pharmaceuticals and medical devices in China and internationally. The company is involved in the planting and sale of Chinese medicinal materials, as well as the provision of related technical and warehousing services. Its drug products cover therapeutic fields, such as anti-infection, cardiovascular, hormones and en… Read more
China Meheco Co Ltd - Asset Resilience Ratio
China Meheco Co Ltd (600056) has an Asset Resilience Ratio of 0.35% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1997–2024)
This chart shows how China Meheco Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down China Meheco Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥128.73 Million | 0.35% |
| Total Liquid Assets | CN¥128.73 Million | 0.35% |
Asset Resilience Insights
- Limited Liquidity: China Meheco Co Ltd maintains only 0.35% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
China Meheco Co Ltd Industry Peers by Asset Resilience Ratio
Compare China Meheco Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950 |
Medical Distribution | 0.00% |
|
Shenzhen Glory Medical Co Ltd
SHE:002551 |
Medical Distribution | 10.46% |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589 |
Medical Distribution | -4.18% |
|
Hanmi Science
KO:008930 |
Medical Distribution | 0.06% |
|
BCM Alliance Bhd
KLSE:0187 |
Medical Distribution | 17.12% |
|
Qingdao Baheal Medical INC.
SHE:301015 |
Medical Distribution | 3.50% |
|
Excelsior Medical Co Ltd
TW:4104 |
Medical Distribution | 3.70% |
|
CHC Healthcare Group
TW:4164 |
Medical Distribution | 0.46% |
Annual Asset Resilience Ratio for China Meheco Co Ltd (1997–2024)
The table below shows the annual Asset Resilience Ratio data for China Meheco Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.36% | CN¥128.73 Million | CN¥35.28 Billion | +0.32pp |
| 2020-12-31 | 0.05% | CN¥16.32 Million | CN¥33.19 Billion | -0.52pp |
| 2019-12-31 | 0.57% | CN¥169.27 Million | CN¥29.83 Billion | -3.73pp |
| 2006-12-31 | 4.30% | CN¥74.29 Million | CN¥1.73 Billion | -3.52pp |
| 2005-12-31 | 7.82% | CN¥130.89 Million | CN¥1.67 Billion | -4.15pp |
| 2004-12-31 | 11.97% | CN¥116.15 Million | CN¥970.44 Million | +11.81pp |
| 2003-12-31 | 0.16% | CN¥1.43 Million | CN¥920.77 Million | -9.57pp |
| 2002-12-31 | 9.72% | CN¥97.40 Million | CN¥1.00 Billion | -6.87pp |
| 2001-12-31 | 16.59% | CN¥200.00 Million | CN¥1.21 Billion | -15.06pp |
| 2000-12-31 | 31.65% | CN¥355.02 Million | CN¥1.12 Billion | +20.48pp |
| 1998-12-31 | 11.17% | CN¥86.28 Million | CN¥772.11 Million | +4.55pp |
| 1997-12-31 | 6.62% | CN¥50.00 Million | CN¥755.14 Million | -- |